Evaluation of the Conformational Stability of Recombinant Desulfurizing Enzymes from a Newly Isolated Rhodococcus sp.

Mol Biotechnol

Department of Biotechnology and Biosciences, State University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.

Published: January 2016

Metabolic pathways of aerobic bacteria able to assimilate sulfur can provide biocatalysts for biodesulfurization of petroleum and of other sulfur-containing pollutants. Of major interest is the so-called "4S pathway," in that C-S bonds are specifically cleaved leaving the carbon skeleton of substrates intact. This pathway is carried out by four enzymes, named Dsz A, B, C, and D. In view of a possible application of recombinant Dsz enzymes in biodesulfurization treatments, we have investigated the structural features of enzymes cloned from a Rhodococcus strain isolated from polluted environmental samples and their resistance to temperature (20-95 °C) and to organic solvents (5, 10, and 20 % v/v methanol, acetonitrile, hexane, and toluene). Changes in protein structures were assessed by circular dichroism and intrinsic fluorescence spectroscopy. We found that all Dsz proteins are unfolded by temperatures in the range 45-60 °C and by all solvents tested, with the most dramatic effect being produced by toluene. These results suggest that stabilization of the biocatalysts by protein engineering will be necessary for developing biodesulfurization technologies based on Dsz enzymes.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12033-015-9897-7DOI Listing

Publication Analysis

Top Keywords

dsz enzymes
8
enzymes
5
evaluation conformational
4
conformational stability
4
stability recombinant
4
recombinant desulfurizing
4
desulfurizing enzymes
4
enzymes newly
4
newly isolated
4
isolated rhodococcus
4

Similar Publications

In this paper, we have analyzed biodesulfurization of dibenzothiophene (DBT) and 4,6-dibenzothiophene (4,6-DMDBT) by 4S metabolic pathway using molecular simulations. Docking analysis revealed lower binding energies and inhibition constants () for 4,6-DMDBT and its metabolic intermediates with DSZ enzymes than DBT and its intermediates. The complexes of substrate and its metabolites with DSZ enzymes had higher stability for 4,6-DMDBT than DBT owing to lower RMSF values than apoprotein.

View Article and Find Full Text PDF

Genetic and metabolic engineering approaches for enhanced biodesulfurization of petroleum fractions.

Front Bioeng Biotechnol

October 2024

Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, India.

Article Synopsis
  • Sulfur in crude oil is harmful to the environment and human health, and it can damage combustion engine catalysts.
  • The traditional method of hydrodesulfurization struggles to remove certain harmful compounds, leading to the need for "ultra-clean" fuels with sulfur content below 15 ppm.
  • Biodesulfurization utilizes engineered microorganisms to effectively reduce sulfur levels in crude oil, and this review focuses on current advancements in genetic and metabolic engineering for improved biodesulfurization techniques.
View Article and Find Full Text PDF

Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.

Lancet Oncol

May 2024

Arthur and Sonia Labatt Brain Tumor Research Centre, Toronto, ON, Canada; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, ON, Canada. Electronic address:

Background: Constitutional mismatch repair deficiency (CMMRD) syndrome is a rare and aggressive cancer predisposition syndrome. Because a scarcity of data on this condition contributes to management challenges and poor outcomes, we aimed to describe the clinical spectrum, cancer biology, and impact of genetics on patient survival in CMMRD.

Methods: In this cohort study, we collected cross-sectional and longitudinal data on all patients with CMMRD, with no age limits, registered with the International Replication Repair Deficiency Consortium (IRRDC) across more than 50 countries.

View Article and Find Full Text PDF
Article Synopsis
  • Pediatric low-grade glioma (pLGG) is mainly caused by genomic changes in the MAPK pathway, particularly KIAA1549::BRAF fusions and BRAF V600E mutations, making it suitable for targeted therapies like tovorafenib instead of traditional treatments.
  • The combination of dabrafenib and trametinib is FDA-approved for BRAF V600E-pLGG but not effective for tumors with BRAF fusions, as it may worsen tumor growth.
  • The LOGGIC/FIREFLY-2 trial is assessing tovorafenib against standard chemotherapy in patients under 25 with pLGG and BRAF mutations, focusing on overall response rate and safety.
View Article and Find Full Text PDF
Article Synopsis
  • The trial demonstrated an overall response rate of 67% and a median duration of response of 16.6 months based on RANO-HGG criteria, while the RAPNO criteria showed an overall response rate of 51% and median duration of response of 13.8 months.
  • Common treatment-related side effects included hair color changes (76%), elevated creatine phosphokinase
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!